Valeda Light Delivery System: A New Era in Non-Invasive Treatment for Dry Age-Related Macular Degeneration
June 16, 2025
Age-related macular degeneration (AMD) is a progressive eye condition that threatens the central vision many people depend on for reading, driving, recognizing faces, and living independently. With a steadily aging population, the prevalence of AMD—particularly the dry form—is rising rapidly. Until recently, treatment options for dry AMD were limited, largely focused on slowing progression rather than improving vision. Enter the Valeda Light Delivery System, an FDA-authorized, non-invasive therapy that uses photobiomodulation (PBM) to stimulate retinal cells, improve cellular health, and potentially restore visual function. For patients diagnosed with dry AMD, this technology offers a proactive, evidence-based approach that goes beyond traditional care methods.
Read More